The mitochondrial benzodiazepine receptor as a potential target protein for drug development: demonstration of functional significance with cell lines exhibiting differential expression of Bcl-2

Toxicol Sci. 2003 Jul;74(1):1-3. doi: 10.1093/toxsci/kfg140.

Abstract

The article highlighted in this issue is "Reversal of Bcl-2 Mediated Resistance of the EW36 Human B-Cell Lymphoma Cell Line to Arsenite and Pesticide-Induced Apoptosis by PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor" by Donna E. Muscarella, Kerry A. O'Brien, Ann T. Lemley, and Stephen E Bloom from Cornell University in Ithaca, NY (pp. 66-73). The following brief review summarizes their findings, highlights the novel biological model and experimental approach used, and explores potential mechanistic and therapeutic implications of these findings.

Publication types

  • Comment

MeSH terms

  • Apoptosis / drug effects*
  • Apoptosis / genetics*
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm / genetics*
  • Genes, bcl-2 / genetics*
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Receptors, GABA-A / drug effects*

Substances

  • Receptors, GABA-A